Export

Pentamidine
Essential medicine status
General description
Pentamidine is an antiparasitic drug used for the treatment of african trypanosomiasis and pneumocystosis.
INN
Pentamidine
Medicine type
Chemical agent
EML status history
First added in 1977 (TRS 615) for Visceral leishmaniasis
Added in 1997 (TRS 882) for Pneumocystosis
Removed in 2009 (TRS 958) for Visceral leishmaniasis
Therapeutic equivalent for
Wikipedia
DrugBank
Recommendations
Section
Antipneumocystosis and antitoxoplasmosis medicines
  • Oral > Solid: 200 mg tablet; 300 mg tablet
Indications
Section
Antileishmaniasis medicines
  • Parenteral > General injections > IM: 200 mg (as isetionate); 300 mg (as isetionate)
Section
Medicines for the treatment of 1st stage African trypanosomiasis
  • Parenteral > General injections > IM: 200 mg (as isetionate) powder for injection